12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Immutep IMMP stock increased by 15.5% to $2.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $344.7 million.
  • Syra Health SYRA stock rose 14.96% to $1.14. The market value of their outstanding shares is at $7.4 million.
  • Sage Therapeutics SAGE shares increased by 13.12% to $14.65. The company's market cap stands at $880.5 million.
  • Recursion Pharmaceuticals RXRX shares moved upwards by 12.72% to $8.68. The market value of their outstanding shares is at $2.0 billion.
  • Viracta Therapeutics VIRX stock moved upwards by 12.05% to $0.95. The company's market cap stands at $37.3 million.
  • BioVie BIVI stock moved upwards by 11.87% to $0.55. The company's market cap stands at $30.2 million.

Losers

  • Evotec EVO shares declined by 32.2% to $5.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out today.
  • Innovative Eyewear LUCY stock decreased by 17.29% to $0.21. The market value of their outstanding shares is at $2.7 million.
  • Ovid Therapeutics OVID stock declined by 15.32% to $2.71. The company's market cap stands at $191.6 million.
  • BiomX PHGE stock decreased by 14.23% to $0.3. The company's market cap stands at $16.4 million.
  • Kiora Pharmaceuticals KPRX stock decreased by 13.84% to $0.5. The market value of their outstanding shares is at $13.1 million.
  • Addex Therapeutics ADXN stock declined by 13.72% to $16.17. The market value of their outstanding shares is at $17.2 million. The company's, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...